Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BIOGEN-INC-4853/news/The-European-Commission-Grants-Marketing-Authorization-for-VUMERITY-diroximel-fumarate-as-Oral-T-37042315/?utm_source=whatsapp&utm_medium=social&utm_campaign=share